BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36587837)

  • 21. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
    Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
    Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of zinc finger E-box binding homeobox factor 1 promotes tumor invasiveness and confers unfavorable prognosis in esophageal squamous cell carcinoma.
    Yang X; Wang Q; Dai W; Zhang J; Chen X
    Tumour Biol; 2014 Dec; 35(12):11977-84. PubMed ID: 25142232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.
    Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G
    Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detention and Identification of Cancer Stem Cells in Esophageal Squamous Cell Carcinoma.
    Islam F; Gopalan V; Lam AK
    Methods Mol Biol; 2020; 2129():177-191. PubMed ID: 32056178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness.
    Xu FP; Liu YH; Luo XL; Zhang F; Zhou HY; Ge Y; Liu C; Chen J; Luo DL; Yan LX; Mei P; Xu J; Zhuang HG
    Cancer Med; 2016 Dec; 5(12):3500-3511. PubMed ID: 27781415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic alterations driving precancerous to cancerous lesions in esophageal cancer development.
    Chang J; Zhao X; Wang Y; Liu T; Zhong C; Lao Y; Zhang S; Liao H; Bai F; Lin D; Wu C
    Cancer Cell; 2023 Dec; 41(12):2038-2050.e5. PubMed ID: 38039962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of HSP47 in esophageal squamous cell carcinoma: clinical implications and functional analysis.
    Lee HW; Kwon J; Kang MC; Noh MK; Koh JS; Kim JH; Park JH
    Dis Esophagus; 2016 Oct; 29(7):848-855. PubMed ID: 25953518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA polymerase iota (Pol ι) promotes invasion and metastasis of esophageal squamous cell carcinoma.
    Zou S; Shang ZF; Liu B; Zhang S; Wu J; Huang M; Ding WQ; Zhou J
    Oncotarget; 2016 May; 7(22):32274-85. PubMed ID: 27057634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing.
    Chen XX; Zhong Q; Liu Y; Yan SM; Chen ZH; Jin SZ; Xia TL; Li RY; Zhou AJ; Su Z; Huang YH; Huang QT; Huang LY; Zhang X; Zhao YN; Yun JP; Wu QL; Lin DX; Bai F; Zeng MS
    Nat Commun; 2017 Sep; 8(1):524. PubMed ID: 28900112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal relationship of synchronous head and neck cancer and esophageal cancer assessed by single nucleotide polymorphism-based loss of heterozygosity analysis.
    Sunpaweravong S; Bunbanjerdsuk S; Pongrujikorn T; Naktang C; Sunpaweravong P; Nitiruangjaras A; Dechaphankul T; Jinawath N
    BMC Cancer; 2019 Dec; 19(1):1174. PubMed ID: 31795956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of esophageal squamous cell carcinoma by cathepsin B activity in nude mice.
    Ma W; Ma L; Zhe H; Bao C; Wang N; Yang S; Wang K; Cao F; Cheng Y; Cheng Y
    PLoS One; 2014; 9(3):e92351. PubMed ID: 24618814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy.
    Hirata H; Niida A; Kakiuchi N; Uchi R; Sugimachi K; Masuda T; Saito T; Kageyama SI; Motomura Y; Ito S; Yoshitake T; Tsurumaru D; Nishimuta Y; Yokoyama A; Hasegawa T; Chiba K; Shiraishi Y; Du J; Miura F; Morita M; Toh Y; Hirakawa M; Shioyama Y; Ito T; Akimoto T; Miyano S; Shibata T; Mori M; Suzuki Y; Ogawa S; Ishigami K; Mimori K
    Cancer Res; 2021 Oct; 81(19):4926-4938. PubMed ID: 34413060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
    Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
    Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA editing of
    Fu L; Qin YR; Ming XY; Zuo XB; Diao YW; Zhang LY; Ai J; Liu BL; Huang TX; Cao TT; Tan BB; Xiang D; Zeng CM; Gong J; Zhang Q; Dong SS; Chen J; Liu H; Wu JL; Qi RZ; Xie D; Wang LD; Guan XY
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):E4631-E4640. PubMed ID: 28533408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
    Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
    J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China.
    Song B; Cui H; Li Y; Cheng C; Yang B; Wang F; Kong P; Li H; Zhang L; Jia Z; Bi Y; Wang J; Zhou Y; Liu J; Wang J; Zhao Z; Zhang Y; Hu X; Shi R; Yang J; Liu H; Yan T; Li Y; Xu E; Qian Y; Xi Y; Guo S; Chen Y; Wang J; Li G; Liang J; Jia J; Chen X; Guo J; Wang T; Zhang Y; Li Q; Wang C; Cheng X; Zhan Q; Cui Y
    Oncotarget; 2016 Jan; 7(3):3599-613. PubMed ID: 26528858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of genomic alterations in oesophageal squamous cell cancer.
    Song Y; Li L; Ou Y; Gao Z; Li E; Li X; Zhang W; Wang J; Xu L; Zhou Y; Ma X; Liu L; Zhao Z; Huang X; Fan J; Dong L; Chen G; Ma L; Yang J; Chen L; He M; Li M; Zhuang X; Huang K; Qiu K; Yin G; Guo G; Feng Q; Chen P; Wu Z; Wu J; Ma L; Zhao J; Luo L; Fu M; Xu B; Chen B; Li Y; Tong T; Wang M; Liu Z; Lin D; Zhang X; Yang H; Wang J; Zhan Q
    Nature; 2014 May; 509(7498):91-5. PubMed ID: 24670651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
    Deng F; Zhou K; Cui W; Liu D; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3045-53. PubMed ID: 26045816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.